James Vollins, GC, chief compliance officer and corporate secretary at BioDelivery Sciences InternationalBioDelivery Sciences Appoints Industry Vet as New GC
The pain management and addiction pharmaceutical company announced that James Vollins is taking over as general counsel, chief compliance officer and corporate secretary at the Raleigh, North Carolina-based company.
November 05, 2018 at 02:49 PM
3 minute read
Pain management and addiction pharmaceutical company BioDelivery Sciences International Inc. announced that industry veteran James “Jim” Vollins is taking over as general counsel.
Vollins' appointment as GC, chief compliance officer and corporate secretary is part of an executive leadership shakeup that includes the retirement of the Raleigh, North Carolina-based company's chief financial officer and corporate secretary next year and the president's additional role of chief commercial officer.
|
➤➤ Get in-house news and commentary straight to your inbox with Inside Track. Sign up here.
Vollins brings more than 12 years of experience working with pharmaceutical and biotechnology companies to BDSI. Most recently, he served as vice president, GC, director of compliance and secretary at international biotech company Bio Products Laboratory, according to his LinkedIn profile.
Prior to that, he held in-house roles at pharma giant Pfizer Inc. and after that at Spanish blood plasma-based products company Grifols. Before going in-house, Vollins was in private practice at Ulmer & Berne and later Squire, Sanders & Dempsey (now Squire Patton Boggs), where he represented corporate clients in diverse commercial matters, including compliance with health care fraud and abuse laws, according to LinkedIn.
In his new role, Vollins succeeds Dan Darnley, who left BDSI last May to become VP and chief intellectual property counsel at Waltham, Massachusetts-based Radius Health Inc., according to Darnley's LinkedIn profile.
Vollins said in an interview Monday that the main priority for his legal department of one is to help BDSI grow in a compliant and appropriate manner and achieve its financial and other strategic objectives.
“BDSI is at an exciting phase of its development with the commercialization of its leading product, Belbuca,” Vollins said. “This is a great opportunity to work for a company that has great growth potential.”
BDSI has two main products: Belbuca, a buprenorphine buccal film to treat chronic pain, and Bunavail, a combination of buprenorphine and naloxone buccal film to treat opioid dependence.
“We are delighted to welcome Jim to our leadership team during this exciting time of rapid company growth,” BDSI CEO Herm Cukier said in a statement announcing Vollins' appointment. “His extensive and wide ranging legal, compliance, and corporate governance experience as part of public companies will further enhance our ability to successfully capitalize on the continued potential of Belbuca growth and beyond.”
Vollins earned his degree from Case Western Reserve University School of Law.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All
People and Purpose: AbbVie's GC on Leading With Impact and Inspiring Change
7 minute read
Sage Therapeutics Axes GC After Drug-Pipeline Failures Force Cost-Cutting
After Guiding Illumina Through Harrowing Merger Fight, GC Charles Dadswell to Depart
Trending Stories
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
